Search company, investor...
RescueDose company logo



Series A | Alive

Total Raised


Last Raised

$2.5M | 6 yrs ago

About RescueDose

RescueDose has developed a compact robot system for dispensing liquid drugs for injection and for filling syringes and IV bags.

Headquarters Location

32 Hameginim Ave.

Haifa, 313320,



Missing: RescueDose's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: RescueDose's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing RescueDose

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

RescueDose is included in 3 Expert Collections, including Robotics.



1,974 items

This collection includes startups developing autonomous ground robots, unmanned aerial vehicles, robotic arms, and underwater drones, among other robotic systems. This collection also includes companies developing operating systems and vision modules for robots.


Medical Devices

8,633 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Health IT

7,901 items

RescueDose Patents

RescueDose has filed 5 patents.

The 3 most popular patent topics include:

  • Clinical research
  • Dosage forms
  • Drug culture
patents chart

Application Date

Grant Date


Related Topics




Medical equipment, Drug delivery devices, Fluid dynamics, Dosage forms, Drug culture


Application Date


Grant Date



Related Topics

Medical equipment, Drug delivery devices, Fluid dynamics, Dosage forms, Drug culture



Latest RescueDose News

With robots dispensing medication, startup hopes to halt deadly errors

Jul 1, 2021

Medical device firm RescueDose has developed devices able to automatically dispense liquid medication at the right doses The UniDose automated dispensing robot for nuclear medicine developed by RescueDose (YouTube screenshot) RescueDose, an Israeli medical device company, has developed a robot that automatically dispenses medication to patients, cutting down on human error that can occur when liquid medications are prepared. The World Health Organization said in 2017 that medication errors caused at least one death every day and injured some 1.3 million people annually in the US alone. These errors cost $42 billion annually, or almost 1% of total global health expenditure. That year, the WHO launched a global initiative to reduce medication associated errors globally by 50% over the next five years. Everyone at some point in their lives will take medicine to treat or prevent illness. But if taken incorrectly, serious harm can be caused, the WHO said. “Medication errors can be caused by health worker fatigue, overcrowding, staff shortages, poor training and the wrong information being given to patients, among other reasons. Any one of these, or a combination, can affect the prescribing, dispensing, consumption, and monitoring of medications, which can result in severe harm, disability and even death. Preventing errors and the harm that results requires putting systems and procedures in place to ensure the right patient receives the right medication at the right dose via the right route at the right time.” It is in this niche that RescueDose, founded in 2006, is positioning itself. The firm’s aim is to do away with manual dispensing to make the process fully automatic. Get The Times of Israel's Daily Editionby email and never miss our top stories Newsletter email address By signing up, you agree to the terms The firm’s first product is a robot aimed at the nuclear medicine market. The robot automatically dispenses accurate doses of radioisotopes — radioactive materials needed when performing medical imaging, for example. This helps keep the doses accurate and cuts back on radiation exposure for staff members. Generally, pharmaceutical staff manually prepare the radioactive dosage, which gets injected into the veins of patients before a scan by preparing it in a specific laminate chamber into which the staff inserts gloved hands to handle the material and prepare the syringes with the correct dose. The UniDose robot developed by RescueDose (Courtesy) The robot is ready for sales, said Eric Ben Mayor, the CEO of the company in a phone interview. Ben Mayor acquired the majority of the shares of RescueDose in 2017 through his holding company ERA Israel-Brazil. The company was founded by Gilad Einy and Dr. Eran Tal-Or, who developed the original technology. The initial robots have since been redeveloped and redesigned, said Ben Mayor. The second robot will dispense medications in powder and liquid forms into ready-to-use IV bags, cutting back on errors when pharmacists prepare patient-specific chemotherapy formulations. The robot software scans the required dosage from the patient’s original prescription — it can also be typed in — and the robot is then able to mix the medicated powders and liquids into the accurate dose, which is then labeled and ready to be delivered to patients. The company has held pilots of its nuclear market UniDose robot with the University of Oklahoma and an unnamed US pharmaceutical group, said Ben Mayor. The pilots showed that the technology was 95% accurate in its dosage preparation, he said. The company is targeting Far East countries like China and Taiwan initially. The ChemiDose robot, for chemotherapy preparations, is still in development, which Ben Mayor hopes will be completed by year end. RescueDose says its competitors’ robots are much heavier and more expensive: RIVA System, which creates automated doses for medications via IV bags, has developed a 900-kilogram (2,000-pound) robot that costs $900,000. The Intellifill IV also creates automated doses for IV bags, with a machine that weighs 680 kilograms and costs $750,000. Omnicell IV Robotic Compounding’s machine weighs 1.2 tons and costs $1 million. The robots developed by RescueDose are five times smaller and 20 times lighter that competing solutions, said Ben Mayor. The 25-kilogram (55-pound) UniDose robot costs $100,000, he said. The ChemiDose will weigh more and cost more, but it is not yet clear by how much, said Ben Mayor. The firm, which has raised $4 million from private investors, is seeking to raise an additional $4 million from private investors that could also be strategic pharmaceutical partners, Ben Mayor said. I'm proud to work at The Times of Israel I’ll tell you the truth: Life here in Israel isn’t always easy. But it's full of beauty and meaning. I'm proud to work at The Times of Israel alongside colleagues who pour their hearts into their work day in, day out, to capture the complexity of this extraordinary place. I believe our reporting sets an important tone of honesty and decency that's essential to understand what's really happening in Israel. It takes a lot of time, commitment and hard work from our team to get this right. Your support, through membership in The Times of Israel Community, enables us to continue our work. Would you join our Community today? Thank you, Sarah Tuttle Singer, New Media Editor

RescueDose Frequently Asked Questions (FAQ)

  • Where is RescueDose's headquarters?

    RescueDose's headquarters is located at 32 Hameginim Ave., Haifa.

  • What is RescueDose's latest funding round?

    RescueDose's latest funding round is Series A.

  • How much did RescueDose raise?

    RescueDose raised a total of $2.5M.

  • Who are the investors of RescueDose?

    Investors of RescueDose include ERA Brazil Israel.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.